Risk of Restrictions on Business Activities Due to the Spread of COVID-19
First written in FY2020. 6 of 12 entries say "Restated". Latest entry: FY2024-Q3.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2024-Q3MitigatedAnnual report
「During the third-quarter consolidated cumulative period, the Japanese and global economies entered a gradual recovery trend as economic activity normalised following the COVID-19 pandemic.」
The Company states that the normalisation of economic activity following the COVID-19 pandemic put the domestic and overseas economies on a gradual recovery trend. - FY2024-Q1MitigatedAnnual report
「During the first-quarter consolidated cumulative period, the Japanese and global economies entered a gradual recovery trend as economic activity normalised following the easing of restrictions on movement related to COVID-19 infections.」
The Company states that restrictions on movement related to COVID-19 infections were eased and economic activity began to normalise. - FY2023-Q3RestatedAnnual report
「During the third-quarter consolidated cumulative period, the Japanese and global economies recovered and entered a gradual recovery trend as the number of infections declined and restrictions on movement were eased, while efforts continued to balance the prevention of COVID-19 infections with economic activity.」
The Company continues to explain that, although the impact of COVID-19 continues, the economy recovered as the number of infections declined and restrictions on movement were eased. - FY2023-Q2RestatedAnnual report
「During the second-quarter consolidated cumulative period, the Japanese and global economies recovered and entered a gradual recovery trend as the number of infections declined and restrictions on movement were eased, while efforts continued to balance the prevention of COVID-19 infections with economic activity.」
The Company continues to explain that, although the impact of COVID-19 continues, the economy recovered as the number of infections declined and restrictions on movement were eased. - FY2023-Q1RestatedAnnual report
「During the first-quarter consolidated cumulative period, the Japanese and global economies recovered and entered a gradual recovery trend as the number of infections declined and restrictions on movement were eased, while efforts continued to balance the prevention of COVID-19 infections with economic activity.」
Although the impact of COVID-19 continues, the economy recovered and entered a gradual recovery trend as the number of infections declined and restrictions on movement were eased, according to the Company. - FY2022-Q3RestatedAnnual report
「During the first nine months of the current fiscal year, the Japanese and global economies entered a gradual recovery trend as they recovered on the easing of restrictions on activities and progress in vaccinations, despite the continuing effects of COVID-19 and the need to balance these effects with economic activity.」
The impact of COVID-19 continues, but the Company continues to explain that economic activity has recovered under vaccination programmes and the easing of restrictions on movement. - FY2022-Q2RestatedAnnual report
「During the first six months of the current fiscal year, the Japanese and global economies remained subject to the need to balance preventing the spread of COVID-19 with the resumption of economic activity. Although the effects of restrictions on activities continued, vaccinations progressed, particularly in developed countries, and the economies entered a gradual recovery trend.」
The impact of restrictions on movement associated with the spread of COVID-19 continues, but the Company explains that the economy has entered a gradual recovery trend as vaccination and the reopening of economic activity progress. - FY2022-Q1RestatedAnnual report
「During the first three months of the current fiscal year, the Japanese and global economies remained subject to the need to balance preventing the spread of COVID-19 with the resumption of economic activity. Vaccinations progressed, particularly in developed countries, but economic conditions continued to be affected by infection levels and recovered only gradually.」
Although vaccination and the reopening of economic activity are progressing, economic conditions continue to be influenced by the infection situation. - FY2021-Q3MaterialisedAnnual report
「Globally, business activities continued amid the spread of COVID-19, but were subject to significant restrictions. In the United States, sales declined to ¥1,313.694 million, down 18.3% year on year.」
Restrictions on business activities due to the spread of COVID-19 continued, with the impact becoming apparent in the form of lower sales in the United States. - FY2021-Q2MaterialisedAnnual report
「During the first six months of the current fiscal year, the Japanese and global economies deteriorated rapidly due to a cooling in consumption and a decline in trade resulting from the stagnation of economic activity associated with the spread of COVID-19, and the situation remained unpredictable.」
The stagnation of economic activity, weakening consumption, declining trade and deterioration in economic conditions associated with the spread of COVID-19 continue to occur. - FY2021-Q1MaterialisedAnnual report
「In the United States and Europe, where the Group has local subsidiaries, business activities continued amid the rapid spread of COVID-19, but were subject to significant restrictions. As a result, sales declined in both regions, to ¥570.845 million in the United States, down 26.1% year on year, and ¥100.974 million in Europe, down 18.8%.」
The spread of COVID-19 placed significant restrictions on business activities in the United States and Europe, and the risk materialised as lower sales in both regions. - FY2020First statedAnnual report
「In addition, if economic stagnation continues due to the outbreak of infectious diseases such as COVID-19, and the Company Group is forced to suspend its business activities, this may materially affect the Group's operating results and other matters.」
The Company identifies as a separate risk the possibility that infectious diseases such as COVID-19 may restrict economic and business activities and materially affect operating results and other matters.